Corcym manufactures heart valve prostheses and repair devices specifically designed to treat structural heart disease. Their products provide effective solutions for patients with aortic valve disease, enhancing surgical outcomes and improving quality of life.
Funding
$49.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with structural heart disease often require heart valve prostheses or repair devices to address aortic valve-related issues. The effectiveness and longevity of these devices are critical for improving patient outcomes and overall quality of life.
Solution
Corcym is a medical device company focused on providing solutions for structural heart disease, specializing in heart valve prostheses and repair devices. Their offerings are designed to address the challenges associated with aortic valve disease, providing surgeons with advanced platforms backed by clinical evidence. By focusing on innovation and collaboration with healthcare professionals, Corcym aims to improve the lives of patients requiring surgical interventions for heart valve-related conditions. The company leverages peer-to-peer exchange and partnerships with scientific societies to promote advanced clinical practices.
Target Audience
The primary audience includes heart surgeons and healthcare professionals specializing in cardiac and cardiothoracic surgery, as well as patients requiring treatment for aortic valve disease and other structural heart conditions.
Features
- Heart valve prostheses designed for aortic valve disease
- Repair devices for structural heart conditions
- Sutureless aortic heart valves
- Mechanical valves
- Platforms backed by clinical evidence
- Professional education experiences for healthcare providers
- Support for minimally invasive cardiac surgery techniques